Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

  1. Garnett, S.A.
  2. Martin, M.
  3. Jerusalem, G.
  4. Petruzelka, L.
  5. Torres, R.
  6. Bondarenko, I.N.
  7. Khasanov, R.
  8. Verhoeven, D.
  9. Pedrini, J.L.
  10. Smirnova, I.
  11. Lichinitser, M.R.
  12. Pendergrass, K.
  13. Lindemann, J.P.O.
  14. Di Leo, A.
Revue:
Breast Cancer Research and Treatment

ISSN: 1573-7217,  0167-6806

Année de publication: 2013

Volumen: 138

Número: 1

Pages: 149-155

Type: Article

DOI: 10.1007/S10549-012-2395-8 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus